Cargando…
Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in Mice
Current monitoring of acute lymphoblastic leukemia (ALL) in living mice is based on FACS analysis of blood hCD45+ cells. In this work, we evaluated the use of human IGFBP2, B2M or Hsp90 as soluble markers of leukemia. ELISA for B2M and IGFBP2 resulted in high background levels in healthy animals, pr...
Autores principales: | Milani, Mateus, Laranjeira, Angelo Brunelli Albertoni, de Vasconcellos, Jaíra Ferreira, Brandalise, Silvia Regina, Nowill, Alexandre Eduardo, Yunes, José Andrés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466233/ https://www.ncbi.nlm.nih.gov/pubmed/26068922 http://dx.doi.org/10.1371/journal.pone.0129298 |
Ejemplares similares
-
Correction: Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in Mice
por: Milani, Mateus, et al.
Publicado: (2015) -
SB225002 Induces Cell Death and Cell Cycle Arrest in Acute Lymphoblastic Leukemia Cells through the Activation of GLIPR1
por: de Vasconcellos, Jaíra Ferreira, et al.
Publicado: (2015) -
PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia
por: Silveira, André Bortolini, et al.
Publicado: (2015) -
Correction: Plasma Hsp90 Level as a Marker of Early Acute Lymphoblastic Leukemia Engraftment and Progression in Mice
Publicado: (2015) -
Structural Basis of Colchicine-Site targeting Acylhydrazones active against Multidrug-Resistant Acute Lymphoblastic Leukemia
por: Cury, Nathália Moreno, et al.
Publicado: (2019)